Fondation Ophtalmologique Adolphe de Rothschild
🇫🇷France
Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas
Completed
- Conditions
- Estimate, With the Contribution of Optimized MRI, the Prevalence of Neurological and Neurovascular Manifestations on Imaging in the Event of SARS-CoV-2
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2023-12-20
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Target Recruit Count
- 100
- Registration Number
- NCT04448054
- Locations
- 🇫🇷
Fondation A De Rothschild, Paris, France
Determination of the Validity of a Questionnaire to Assess the Visual Function of Preverbal Children with Operable Bilateral Ocular Pathologies
Not Applicable
Recruiting
- Conditions
- Eye DiseasesVision Disorders
- Interventions
- Other: Questionnaire for visual function assessment of preverbal children
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Target Recruit Count
- 150
- Registration Number
- NCT04428541
- Locations
- 🇫🇷
Fondation A de Rothschild, Paris, France
Study of the Sars-Cov2 Neuroinvasiveness - COVID19
Not Applicable
Terminated
- Conditions
- COVID19
- Interventions
- Drug: Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Target Recruit Count
- 2
- Registration Number
- NCT04427254
- Locations
- 🇫🇷
Fondation A de Rothschild, Paris, France
Study of Retinal Vascular Parameters in Patients With Wilson's Disease
Not Applicable
Completed
- Conditions
- Wilson Disease
- Interventions
- Procedure: Ophthalmological exam
- First Posted Date
- 2020-05-29
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Target Recruit Count
- 124
- Registration Number
- NCT04408300
- Locations
- 🇫🇷
Hôpital Fondation A. de Rothschild, Paris, France
Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents
Completed
- Conditions
- Retinal Vein OcclusionDiabetic Macular EdemaAge Related Macular Degeneration
- Interventions
- Procedure: QuestionnaireOther: Data collection up to 1 year
- First Posted Date
- 2020-05-20
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Target Recruit Count
- 233
- Registration Number
- NCT04395859
- Locations
- 🇫🇷
Centre Pôle Vision du val d'Ouest, Ecully, France
🇫🇷Fondation Adolphe de Rothschild, Paris, France
🇫🇷Hôpital Lariboisière, Paris, France
OCT-Angiography and Adaptive Optics in Patients With Memory Impairment
Not Applicable
Recruiting
- Conditions
- Parkinsons Disease With DementiaAmnesiaLewy Body DiseaseAlzheimer Disease
- Interventions
- Procedure: Ophthalmological examProcedure: Blood pressure measurement
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Target Recruit Count
- 450
- Registration Number
- NCT04389437
- Locations
- 🇫🇷
Hôpital Fondation A. de Rothschild, Paris, France
Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19
Not Applicable
Completed
- Conditions
- Covid19Sars-CoV2
- Interventions
- Procedure: Ophthalmologic exam
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2020-11-16
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Target Recruit Count
- 23
- Registration Number
- NCT04385810
- Locations
- 🇫🇷
Fondation Adolphe de Rothschild, Paris, France
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
Not Applicable
Completed
- Conditions
- OphthalmopathyCOVID19
- Interventions
- Procedure: Ophthalmologic exam
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2021-08-03
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Target Recruit Count
- 34
- Registration Number
- NCT04387292
- Locations
- 🇫🇷
Fondation A de Rothschild, Paris, France
Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity
Phase 3
Completed
- Conditions
- SARS-CoV-2Olfaction DisordersAnosmiaBudesonide
- Interventions
- Other: Physiological serum
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2021-08-03
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Target Recruit Count
- 120
- Registration Number
- NCT04361474
- Locations
- 🇫🇷
Amélie YAvchitz, Paris, France
Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)
Phase 3
Terminated
- Conditions
- COVID-19Acute Respiratory Distress Syndrome
- Interventions
- Drug: Dornase Alfa Inhalation Solution [Pulmozyme]Procedure: standard procedure
- First Posted Date
- 2020-04-21
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Target Recruit Count
- 77
- Registration Number
- NCT04355364
- Locations
- 🇫🇷
Hôpital Fondation A. de Rotschhild, Paris, France
© Copyright 2025. All Rights Reserved by MedPath